Objective To compare the risk for all cause and overdose mortality in people with opioid
dependence during and after substitution treatment with methadone or buprenorphine and …

Abstract The United States opioid epidemic is a nationwide public health crisis. Initially
driven by increased consumption and availability of pharmaceutical opioids, an increasing …

OBJECTIVES: To describe incidence, health care use, and cost trends for infants with
neonatal abstinence syndrome (NAS) who are covered by Medicaid compared with other …

Methods The Canadian Research Initiative in Substance Misuse (CRISM), a Canadian
Institutes of Health Research (CIHR)–funded research network composed of four regional …

Purpose Opioid use disorder (OUD) is a substantial public health problem. Buprenorphine is
an effective medication‐assisted treatment (MAT) for OUD, but access is difficult for patients …

Importance Retention in addiction treatment is associated with reduced mortality for
individuals with opioid use disorder (OUD). Although clinical trials support use of OUD …

Substance use disorders (SUDs), defined as a collection of symptoms including tolerance
and withdrawal, are chronic illnesses characterized by relapse and remission. In the United …

Objective: The authors present 12-month and lifetime prevalence, correlates, psychiatric
comorbidity, and treatment of nonmedical prescription opioid use (NMPOU) and DSM-5 …

Opioid use disorder is a serious public health problem. Management with buprenorphine is
an effective, office-based, medication-assisted treatment, but 60.1% of rural counties in the …

Background and Objectives Buprenorphine's high‐binding affinity as a partial µ‐opioid
agonist displaces preexisting full agonists causing precipitated withdrawal, which requires …